IMPROVING TODAY’S MEDICINE FOR BETTER PATIENT OUTCOMES TOMORROW

Seek ways to improve therapeutic outcomes without researching new chemical entities.

  • New chemical entities are extremely expensive. The company is focused on enhancing existing products, thereby reducing the cost of therapy.

Provide cost-effective pharmaceuticals that allow for maximum patient compliance.

  • Pharmaceutical care is constrained by patients’ willingness to comply with physician prescribing. Patients do not take medicine correctly for many reasons, but cost, dosing and side effects are key issues in the lack of patient compliance. Éclat hopes to enhance patient compliance by minimizing or even eliminating these issues through science.

Provide physicians and patients high-quality pharmaceutical products, manufactured in a fully cGMP compliant fashion.

  • The company is highly selective; willing only to partner with companies whose background in developing and manufacturing products is pristine. Product effectiveness and patient safety will not be compromised.